HRSA-26-038: Rural Communities Opioid Response Program (RCORP)-Technical Assistance
Closed
This grant is closed. A newer notice from the same program is forecast: Rural Communities Opioid Response Program - Child and Adolescent Behavioral Health (HRSA-27-043). Status: Expected deadline March 23, 2027. It is in our archive of Health Resources and Services Administration notices from 2026.
Health Resources and Services Administration offered grants of up to $10.0 million to any type of organization. It expected to make one award worth $10.0 million in total. Applications closed on July 27, 2026.
From the official notice on Grants.gov, last changed June 25, 2026. Checked November 7, 2026.
- Award ceiling$10.0 million
- Total funding$10.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | June 25, 2026 |
|---|---|
| Deadline | July 27, 2026 |
Who can apply
This opportunity was open to any type of organization.
All 15 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
You can apply if you are a domestic public or private, non-profit or for-profit entity.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The purpose of the Rural Communities Opioid Response Program-Technical Assistance (RCORP-TA) is to connect rural communities with high-quality, comprehensive, and tailored resources and supports to implement and sustain behavioral health care, including prevention, treatment, and recovery services, to address the opioid epidemic and related substance use concerns in rural areas. RCORP-TA supports and complements other RCORP investments to address the crisis of substance use disorder, including opioid use disorder, in rural areas, prevent substance misuse and its impacts, and promote long-term, sustained well-being.
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-043, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-26-038 still open?
No. It closed on July 27, 2026. A newer notice is forecast: HRSA-27-043, expected deadline March 23, 2027.
Who can apply for Rural Communities Opioid Response Program (RCORP)-Technical Assistance?
Health Resources and Services Administration accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Rural Communities Opioid Response Program (RCORP)-Technical Assistance?
Closed July 27, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $10.0 million each. About $10.0 million in total for one award.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)